Peritoneal adhesions — DVA SoP factors

Reasonable Hypothesis (RH) — Statement of Principles No. 9 of 2025

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting peritoneal adhesions or death from peritoneal adhesions with the circumstances of a person's relevant service:

1. (1)
   having peritonitis at least 3 days before clinical onset;
2. (2)
   having one of the following diseases at least 3 days before clinical onset: (a) appendicitis; (b) cholecystitis; (c) diverticulitis; (d) endometriosis; (e) inflammatory bowel disease; (f) pancreatitis; (g) pelvic inflammatory disease;
3. (3)
   having intra-abdominal or pelvic surgery at least 3 days before clinical onset;
4. (4)
   having penetrating trauma to the abdomen that enters the peritoneal cavity at least 3 days before clinical onset;
5. (5)
   undergoing a course of ablative radiotherapy for cancer, where the abdominopelvic region was in the field of radiation, at least 3 days before clinical onset;
6. (6)
   having a bacterial, fungal or Echinococcus granulosus infection involving the peritoneal cavity at least 3 days before clinical onset;
7. (7)
   having a perforation of the hollow viscus into the peritoneal cavity at least 3 days before clinical onset;

   Note: A perforated hollow viscus could include a perforated stomach, gallbladder, intestine, appendix, renal pelvis, ureter, bladder, or uterus.

8. (8)
   undergoing peritoneal dialysis for at least 6 months duration before clinical onset;
9. (9)
   undergoing intraperitoneal chemotherapy with cisplatin, oxaliplatin, carboplatin, 5-fluorouracil, mitoxantrone (mitozantrone), or mitomycin C at least 3 days before clinical onset;
10. (10)
    having a primary or secondary malignant neoplasm involving the peritoneum at least 3 days before clinical onset;
11. (11)
    having an ovarian dermoid cyst rupturing into the peritoneum at least 3 days before clinical onset;
12. (12)
    having a ventriculoperitoneal shunt at least 3 days before clinical onset;
13. (13)
    having a peritoneovenous shunt at least 3 days before the clinical onset of encapsulating peritoneal sclerosis;
14. (14)
    having hernia mesh inserted in the abdomen at the site of the subsequent peritoneal adhesions at least 3 days before clinical onset;
15. (15)
    having a retained surgical sponge at least 3 days before clinical onset;
16. (16)
    taking practolol for at least 1 year before clinical onset;
17. (17)
    having peritoneal sarcoidosis at the time of clinical onset;